# Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

> **NCT05316701** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Orca Biosystems, Inc.** · enrollment: 187 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia
- Mixed Phenotype Acute Leukemia
- Undifferentiated Leukemia
- Myelodysplastic Syndrome
- Acute Leukemia
- Therapy-Related Myelodysplastic Syndrome

## Interventions

- **BIOLOGICAL:** Orca-T
- **BIOLOGICAL:** Standard-of-Care

## Key facts

- **NCT ID:** NCT05316701
- **Lead sponsor:** Orca Biosystems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-21
- **Primary completion:** 2024-07-15
- **Final completion:** 2026-07
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05316701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05316701, "Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05316701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*